Dr. Kalyanasundara Venkataraman, MD

Dr. Venkataraman practices at City of Hope Comprehensive Cancer Center - Duarte in Duarte, California.

Dr. Venkataraman's NPI, 1831284777, was assigned on October 4, 2006. Dr. Venkataraman graduated from Madurai Medical College in 1963. Dr. Venkataraman holds California license A26371.

Dr. Venkataraman's primary practice is City of Hope Comprehensive Cancer Center - Duarte, at 1500 Duarte Rd, Duarte, CA 91010 in Los Angeles County. The practice phone is (800) 826-4673.

Dr. Venkataraman's primary practice is City of Hope Comprehensive Cancer Center - Duarte in Duarte, California. The medical group on file is City of Hope. Dmand AI also links Dr. Venkataraman to 1 more other site, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Venkataraman practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Venkataraman's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Venkataraman is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Venkataraman is licensed in California.

Dmand AI lists aneurysm, atrial fibrillation and flutter, cardiomyopathy, chronic hypertension, coronary artery disease, heart failure, heart valve disorders and high cholesterol among the conditions Dr. Venkataraman treats.

CMS data shows 413 Medicare services from Dr. Venkataraman across 5 procedure codes in 2024, all of them office visits, for 218 Medicare patients. Medicare paid $34,692 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 218 Medicare patients who saw Dr. Venkataraman in 2024. The largest group is 65 to 74, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 34% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Venkataraman's median patient age at 72, with 58% women.

In 2024, Dr. Venkataraman wrote 1,316 Medicare Part D claims for 172 patients. 89% of them were for generic drugs. CMS names the drug for 1,163 of them, across 29 drugs with 11 or more claims each, at $110,767 in total drug cost. In 2023, CMS named 1,148 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Venkataraman for performance year 2024, reported as part of a group.

Dmand AI links 16 papers to Dr. Venkataraman in 2019. The most frequent topics are Electrocardiography, Heart Rate and Blood Pressure. Dr. Venkataraman has published most often in Am J Cardiol. Dr. Venkataraman's most frequent co-authors are Dinesh Raghunath Samant, MD, Uday G. Gadgil, MD and Stephen J. Forman, MD.

CMS Open Payments shows 3 general payments to Dr. Venkataraman from 3 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $51.

Dr. Venkataraman graduated from Madurai Medical College in 1963.

Dr. Venkataraman is in network with 5 carriers, including Blue Cross Blue Shield of Michigan, Blue Cross Blue Shield of Massachusetts and HCSC. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.